Insider Selling: Axon Enterprise, Inc. (NASDAQ:AXON) Director Sells 307 Shares of Stock

Axon Enterprise, Inc. (NASDAQ:AXON) Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Axon Enterprise Trading Down 2.7 %

NASDAQ:AXON opened at $539.99 on Wednesday. The stock has a fifty day moving average price of $592.66 and a two-hundred day moving average price of $539.27. The stock has a market capitalization of $41.38 billion, a price-to-earnings ratio of 139.53, a PEG ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.

Hedge Funds Weigh In On Axon Enterprise

A number of large investors have recently made changes to their positions in the stock. 111 Capital purchased a new stake in Axon Enterprise during the fourth quarter worth about $280,000. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Axon Enterprise by 36.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 16,932 shares of the biotechnology company’s stock worth $10,063,000 after acquiring an additional 4,510 shares in the last quarter. Lansforsakringar Fondforvaltning AB publ purchased a new position in Axon Enterprise in the 4th quarter valued at approximately $13,986,000. Centaurus Financial Inc. boosted its position in Axon Enterprise by 43.9% during the fourth quarter. Centaurus Financial Inc. now owns 6,517 shares of the biotechnology company’s stock worth $3,873,000 after purchasing an additional 1,989 shares in the last quarter. Finally, Wealthedge Investment Advisors LLC purchased a new stake in Axon Enterprise during the fourth quarter worth $1,677,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

AXON has been the subject of a number of analyst reports. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Robert W. Baird increased their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.